Cite
APA Citation
Lala, M., Li, T. R., de Alwis, D. P., Sinha, V., Mayawala, K., Li, M., Yamamoto, N., Siu, L. L., Chartash, E., Aboshady, H., & Jain, L. (2021). corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68–75]. European journal of cancer, 144, 400–. http://access.bl.uk/ark:/81055/vdc_100120049974.0x000023